SCHEMBL7052307

SCHEMBL7052307

C#CN(C(=O)c1ccccc1)c1ccccc1S(=O)(=O)NC(=O)C=C(C)C.c1cc2ccc1-2

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
MAPT P10636 1/20 0.33
LMNA P02545 1/20 0.33
PTGES O14684 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
AGTR1 P30556 3/20 0.31
AGTR2 P50052 3/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
HSD11B1 P28845 1/20 0.31
BCL2L1 Q07817 1/20 0.31
MCL1 Q07820 1/20 0.31
DEGS1 O15121 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049851 0.88 AKR1C2 (0.38) ALDH1A1HPGDMAPTLMNAPTGES
SCHEMBL7050679 0.84 ALDH1A1 (0.32) ALDH1A1HPGDMAPTLMNAPTGES
SCHEMBL7052349 0.83 MAPT (0.35) ALDH1A1HPGDMAPTLMNAPTGES
SCHEMBL7049824 0.79 HPGD (0.36) ALDH1A1HPGDMAPTKMT2AAGTR1
SCHEMBL7076349 0.79 BCL2L1 (0.43) LMNAPTGESNPC1RAB9AHSD11B1
SCHEMBL7048489 0.78 POLB (0.43) ALDH1A1HPGDMAPTAGTR1AGTR2
SCHEMBL7051028 0.77 POLB (0.42) HPGDMEN1KMT2AAGTR1AGTR2
SCHEMBL7076569 0.74 SMPD1 (0.53) BCL2L1MCL1
SCHEMBL4560019 0.62 L3MBTL1 (0.46) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL3637063 0.57 LMNA (0.68) ALDH1A1HPGDLMNAPTGESMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN ALDH1A1 385/4885HPGD 3434/4885MAPT 3922/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 ALDH1A1 410/4885HPGD 1451/4885MAPT 4390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.